NCT07179471 Fake Carbs Practice With AID System - MiniMed 780G in Children and Adolescents With T1D.
| NCT ID | NCT07179471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maria Chatzipsalti |
| Condition | Type 1 Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-04 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-06-04 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hybrid Closed Loop (HCL) systems, such as the MiniMed 780G, have significantly improved glycemic outcomes in Type 1 Diabetes (T1D) management. The MiniMed 780G, an Advanced Hybrid Closed Loop (AHCL) system, features autocorrection boluses and unique insulin adjustment technologies. While effective, the system requires user input for meal announcements. Some individuals attempt to "trick" the system by entering "fake carbs" to prompt additional insulin corrections. However, clinical evidence suggests this practice does not improve glycemic outcomes. This study, conducted in Athens, Greece, will involve 40 children and adolescents (ages 7-18) with Type 1 Diabetes who have been using the MiniMed 780G system for over 6 months. The open-label, crossover design explores the impact of 'fake carbohydrates' on glycemic control. Participants will be split into two groups: one starts with 'fake carbohydrates' and then stops, while the other does the reverse. Over two weeks, their glycemic outcomes will be monitored and compared, with exclusions for severe diabetes complications or serious diabetic events This study hypothesizes that using "fake carbs" does not enhance glycemic control. Findings are expected to provide evidence-based insights to optimize diabetes management and improve clinical guidance for HCL system users.
Eligibility Criteria
Inclusion Criteria: * Participants aged 7-18 years * T1D \>6 months * on MiniMed 780G system in automode. Exclusion Criteria: * Participants with significant diabetes complications * Participants with severe episode of diabetic ketoacidosis in the last 6 months * Participants with hypoglycemia in the last 6 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07179471 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 19 Years, studying Type 1 Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07179471 currently recruiting?
Yes, NCT07179471 is actively recruiting participants. Contact the research team at endo1ped@aglaiakyriakou.gr for enrollment information.
Where is the NCT07179471 trial being conducted?
This trial is being conducted at Athens, Greece, Athens, Greece, Athens, Greece.
Who is sponsoring the NCT07179471 clinical trial?
NCT07179471 is sponsored by Maria Chatzipsalti. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.